Dyax Corp.

Patent Owner

Compare Add to Portfolio
2Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 64183
 
 
 
C07K PEPTIDES 4970
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 28124
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 20154
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1874
 
 
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 1712
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 13107
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 957
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 692
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 5202

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0218,218 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (CMET) AND USES THEREOFFeb 19, 15Aug 06, 15[C07K]
2015/0158,932 NOVEL METHODS OF CONSTRUCTING LIBRARIES COMPRISING DISPLAYED AND/OR EXPRESSED MEMBERS OF A DIVERSE FAMILY OF PEPTIDES, POLYPEPTIDES OR PROTEINS AND THE NOVEL LIBRARIESDec 01, 14Jun 11, 15[C07K]
2015/0087,533 LIGAND SCREENING AND DISCOVERYSep 26, 14Mar 26, 15[C12N, G01N]
2015/0023,978 ANTI MIF ANTIBODIESJan 17, 14Jan 22, 15[C07K]
2014/0349,940 PREVENTION AND REDUCTION OF BLOOD LOSSApr 28, 14Nov 27, 14[A61K]
2014/0335,023 PLASMA KALLIKREIN BINDING PROTEINSJul 23, 14Nov 13, 14[A61K, C07K]
2014/0335,082 COMBINATION THERAPY COMPRISING AN MMP-14 BINDING PROTEINOct 18, 12Nov 13, 14[A61K]
2014/0308,206 FC RECEPTOR BINDING PROTEINSJun 01, 12Oct 16, 14[A61K, G01N, C07K]
2014/0302,048 PLASMA KALLIKREIN BINDING PROTEINSJun 20, 14Oct 09, 14[C07K]
2014/0286,864 KDR AND VEGF/KDR BINDING PEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPYDec 17, 13Sep 25, 14[A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,107,928 Compositions and methods for treating ophthalmic disordersJun 02, 10Aug 18, 15[A61P, A61K, C07K]
9,068,980 Multi-chain eukaryotic display vectors and uses thereofJun 28, 11Jun 30, 15[C12N, C40B, C12P, G01N]
9,056,138 Multivalent constructs for therapeutic and diagnostic applicationsSep 19, 13Jun 16, 15[A61B, A61K, C07K]
9,051,377 Method for treating breast cancer using antibody binding to MMP-14Dec 22, 11Jun 09, 15[G01N, A61K, C07K]
9,040,258 Multi-chain eukaryotic display vectors and uses thereofJun 28, 11May 26, 15[C12N, C40B, C12P, G01N]
9,034,601 Multi-chain eukaryotic display vectors and uses thereofJul 09, 13May 19, 15[C12N, C40B, C12P, G01N]
9,012,181 Multi-chain eukaryotic display vectors and uses thereofNov 24, 09Apr 21, 15[C12N, C40B, C12P, G01N]
9,005,927 Multi-chain eukaryotic display vectors and uses thereofMar 28, 11Apr 14, 15[C12N, C40B, C12P, G01N]
9,000,124 Peptides that specifically bind HGF receptor (cMet) and uses thereofJul 14, 11Apr 07, 15[A61K, B82Y, C07K]
8,901,045 Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel librariesMay 04, 12Dec 02, 14[C12N, C40B]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0199,324 EVALUATING PROTEIN EXPRESSION IN PATIENT STRATIFICATION AND OTHER THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCERABANMar 23, 12Jul 17, 14[G01N]
2013/0244,890 EVALUATING MMP EXPRESSION IN PATIENT STRATIFICATION AND OTHER THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCERABANApr 24, 12Sep 19, 13[C12Q, G01N]
2013/0189,944 TRACKING AND REPORTING INFORMATION CHARACTERIZING ATTACKS CAUSED BY A DISEASEABANJan 16, 13Jul 25, 13[H04W, G08B]
2013/0045,218 FC RECEPTOR BINDING PROTEINSABANAug 13, 12Feb 21, 13[A61P, A61K, G01N, C07K]
2012/0027,686 HK1-BINDING PROTEINSABANJul 28, 11Feb 02, 12[C12N, C40B, A61P, G01N, A61K]
2011/0300,157 METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINSABANAug 01, 11Dec 08, 11[A61P, A61K, C07K]
2011/0281,360 MULTI-CHAIN EUKARYOTIC DISPLAY VECTORS AND USES THEREOFABANJun 28, 11Nov 17, 11[C12N]
2011/0262,396 COMBINATION TREATMENTS COMPRISING PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISORDERSABANOct 22, 09Oct 27, 11[A61P, A61K]
2011/0172,140 Poly-Pegylated Protease InhibitorsABANMay 26, 09Jul 14, 11[A61P, A61K, C07K]
2011/0165,145 IGF-II/IGF-IIE BINDING PROTEINSABANMay 08, 09Jul 07, 11[A61P, A61K, C07K]
2011/0152,193 INHIBITORS OF HUMAN PLASMIN DERIVED FROM THE KUNITZ DOMAINSABANFeb 25, 11Jun 23, 11[A61P, A61K]
2011/0135,573 METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINSABANSep 02, 10Jun 09, 11[C12N, A61P, G01N, A61K, C07K]
2011/0092,413 Albumin-Fused Kunitz Domain PeptidesABANNov 02, 10Apr 21, 11[C12N, C12P, A61P, A61K, C07K]
2011/0082,054 LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR3 DESIGNSABANSep 14, 10Apr 07, 11[C40B]
7,919,462 Inhibitors of human plasmin derived from the Kunitz domainsExpiredOct 30, 07Apr 05, 11[A61K]
2011/0059,105 TIE COMPLEX BINDING PROTEINSABANJun 28, 10Mar 10, 11[A61P, G01N, A61K, C07K]
7,893,007 Directed evolution of novel binding proteinsExpiredOct 22, 08Feb 22, 11[C40B]
2010/0291,001 METALLOPROTEINASE-BINDING PROTEINSABANDec 19, 08Nov 18, 10[C12N, C07H, A61P, C12P, G01N, A61K, C07K]
2010/0286,061 PLASMIN-INHIBITORY THERAPIESABANNov 23, 09Nov 11, 10[A61P, A61K]
2010/0260,672 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (CMET) AND USES THEREOFABANDec 10, 09Oct 14, 10[A61B, A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.